In an early stage clinical trial, Moderna’s COVID-19 vaccine produced antibodies that will help ‘neutralize’ coronavirus in patients. Moderna CEO Stéphane Bances joins Yahoo Finance’s On the Move to discuss.
ImagineAR Receives Additional $1,000,000 From Exercise Of Warrants For A Total Of Approximately $4,500,000 In 2020. Launches Moderated Forum On AGORACOM To Directly Engage Investors & Answer Questions